A Phase 2, 2-Stage, 2-Cohort Study of Talazoparib (BMN 673), in Locally Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (ABRAZO Study) (ABRAZO)
This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2015 by Medivation, Inc.
Translational Research in Oncology
Myriad Genetic Laboratories, Inc.
Information provided by (Responsible Party):
First received: January 9, 2014
Last updated: December 21, 2015
Last verified: December 2015
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Estimated Study Completion Date:||No date given|
|Estimated Primary Completion Date:||December 2015 (Final data collection date for primary outcome measure)|